Aurobindo Pharma Wins Company of the Year and Acquisition of the Year Awards at the Global Generics & Biosimilars Awards 2019

Aurobindo Pharma Limited (BSE: 524804 and NSE: AUROPHARMA) ("Aurobindo"), a world-leading marketer and manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, is pleased to announce that it won two prestigious awards at the 6th Global Generics & Biosimilars Awards 2019 ceremony held on 5th November 2019 in Frankfurt, Germany: Company of the Year and Acquisition of the Year.

Aurobindo has been recognised as the Company of the Year for its outstanding development, innovation and success over the past year. The Acquisition of the Year award was given to Aurobindo following its acquisition of Sandoz Inc., USA's dermatology and oral solids businesses in the United States..